- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Therapeutics
Synageva BioPharma Corp
+ Add to WatchlistGEVA:US
40.8800 USD 0.2900 0.71%As of 20:10:00 ET on 05/24/2013.
Company Profile for Synageva BioPharma Corp (GEVA)
Synageva BioPharma Corp. is a clinical stage biopharmaceutical company. The Company is focused on the discovery, development, and commercialization of therapeutic products for patients with life-threatening rare diseases and unmet medical need.
Contact Information
Synageva BioPharma Corp
128 Spring Street
Suite 520
Lexington, MA 02421
United States
Key Executives for Synageva BioPharma Corp (GEVA)
| Sanj K PatelPresident/CEO/Secretary | Carsten BoessSenior VP/CFO |
| Anthony G QuinnSenior VP/Chief Medical Offcr | Marc E GoldbergSenior VP:Product Dev |
| Glen WilliamsSenior VP:Global Technical Ops |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Advertisements
Rate this Page